Genmab — Juli 2017
-
What to watch for as Novartis heads to the FDA with a novel cancer therapy (CAR-T) https://www.statnews.com/2017/07/10/novartis-fda-cancer-car-t/
-
Genmab employee film 2017 https://www.youtube.com/watch?v=Rnb8-c3FFs4
-
@E L Thanks for the Novartis CAR-T link. Interesting what will happen to this technology. Some appear to believe that KITE will benefit from the Novartis hearing http://www.investors.com/news/technology/novartis-is-going-before-the-fda-but-kite-could-benefit-more/?src=A00220&yptr=yahoo
-
God morgen :-9
-
Ved en investorpræsentatione for nogle måneder siden sagde Jan, at telefonen hos Janssen var rødglødende, for der var så mange der ville lave kombinationer med Daratumumab. Umiddelbart er jeg en lille smule skuffet over der ikke sker mere - hvad tænker i andre ?
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind